We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04474457
Recruitment Status : Unknown
Verified January 2021 by Prof. Ates KARA, MD, Hacettepe University.
Recruitment status was:  Active, not recruiting
First Posted : July 16, 2020
Last Update Posted : February 1, 2021
Hacettepe University, School of Medicine
Prof. Dr. Cemil Tascıoglu City Hospital
Umraniye Training and Research Hospital
Istanbul Training and Research Hospital
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Tepecik Training and Research Hospital
Istanbul University - Cerrahpasa (IUC)
Ankara University
Ankara City Hospital Bilkent
Ankara Training and Research Hospital
Ege University Hospital (Application and Research Center)
Derince Training and Research Hospital
Istanbul University
Kayseri City Hospital
Information provided by (Responsible Party):
Prof. Ates KARA, MD, Hacettepe University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Actual Primary Completion Date : December 31, 2020
Estimated Study Completion Date : June 1, 2021